![1]()
News
Hospitalist movers and shakers – March 2020
March 18, 2020
Take note of some recent career transitions in the hospital medicine community.
News
COVID-19: U.S. cardiology groups reaffirm continued use of RAAS-active drugs
March 18, 2020
Experts give ACE inhibitors and ARBs, cornerstones of cardiology therapy, a thumbs up despite a hypothetical adverse COVID-19 effect.
![1]()
Opinion
COVID-19 guidance for children’s health care providers
March 18, 2020
Accurate information calmly delivered is the antidote to anxiety or panic in a stressful situation.
Opinion
Physicians and health systems can reduce fear around COVID-19
March 18, 2020
“We must look after our patients. But we also have to look after ourselves so that we can look after our patients,” said Dr. Peter M. Yellowlees.
News
FDA advises stopping SGLT2 inhibitor treatment prior to surgery
March 18, 2020
The changes affect canagliflozin, dapagliflozin, empagliflozin, and ertugliflozin, and were made because surgery may put patients taking SGLT2 inhibitors at a higher risk of ketoacidosis.
![1]()
News
PARAGON-HF: Optimal systolic pressure in HFpEF is 120-129 mm Hg
March 18, 2020
In largest-ever HFpEF trial, SBP of 120-129 mm Hg was associated with lowest cardiovascular risk.
![1]()
Opinion
COVID-19 in pediatric patients: What the hospitalist needs to know
March 17, 2020
Children could be very efficient vectors of COVID-19 and potentially spread the pathogen to vulnerable populations.
![1]()
News
Coronavirus stays in aerosols for hours, on surfaces for days
March 17, 2020
Aerosol and fomite transmission of SARS-CoV-2 are plausible.
News
Potential GI manifestation, transmission of coronavirus
March 17, 2020
The virus appears to infect and could potentially spread through the gastrointestinal route.
![1]()
News
ICH survival lags in the community setting
March 17, 2020
LOS ANGELES – An observed 6-month mortality of 64% in a Dutch study contrasts with better survival in interventional trials.
